https://www.selleckchem.com/pr....oducts/ory-1001-rg-6
The identification of BRAF alterations may assist clinicians in determining alternative targeted treatment strategies, especially considering the paucity of effective treatments for primary brain tumors and the poor prognosis associated with many central nervous system (CNS) diagnoses. Additional case studies or larger cohort reports will continue to clarify the efficacy of BRAF and/or MEK inhibitors in patients whose tumors harbor a BRAF alteration. Transplant centers in Europe aim to minimize the time from brain death to orga
Like
Comment
Share
